PlainRecalls
FDA Drug Moderate Class II Terminated

FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag, Injection for Epidural Use (fentaNYL Concentration - 2 mcg/mL), Rx Only, Single Dose Container, SCA Pharmaceuticals, 755 Rainbow Rd, Windsor, CT 06095, NDC# 70004-0253-40

Reported: August 2, 2023 Initiated: July 20, 2023 #D-0945-2023

Product Description

FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag, Injection for Epidural Use (fentaNYL Concentration - 2 mcg/mL), Rx Only, Single Dose Container, SCA Pharmaceuticals, 755 Rainbow Rd, Windsor, CT 06095, NDC# 70004-0253-40

Reason for Recall

cGMP deviations: due to shipment of rejected units.

Details

Recalling Firm
SCA Pharmaceuticals
Units Affected
183 bags
Distribution
KY and NJ
Location
Windsor, CT

Frequently Asked Questions

What product was recalled?
FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag, Injection for Epidural Use (fentaNYL Concentration - 2 mcg/mL), Rx Only, Single Dose Container, SCA Pharmaceuticals, 755 Rainbow Rd, Windsor, CT 06095, NDC# 70004-0253-40. Recalled by SCA Pharmaceuticals. Units affected: 183 bags.
Why was this product recalled?
cGMP deviations: due to shipment of rejected units.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 2, 2023. Severity: Moderate. Recall number: D-0945-2023.